Here is the synopsis of our sample research paper on Treating Hordeolum. Have the paper e-mailed to you 24/7/365.
Essay / Research Paper Abstract
A 4 page outline for a speech informing the audience about hordeolum, or stye. The outline identifies the antibiotics and forms used for treatment, discussing their modes of action and whether there are additional considerations for special populations including children and pregnant women. Bibliography lists 4 sources.
Page Count:
4 pages (~225 words per page)
File: CC6_KSmedHordeo.rtf
Buy This Term Paper »
Unformatted sample text from the term paper:
and clarity. JM-C Introduction Hordeolum commonly is referred to as stye, "a localized infection or inflammation of the eyelid margin" (Bessette, 2004).
An external hordeolum involves eyelash hair follicles; an internal hordeoloum involves the meibomian glands (Bessette, 2004). I. Cause and Diagnosis A. The causative agent almost always (in 90 - 95%
of cases) is Staphylococcus aureus (Bessette, 2004), a gram-positive coccus bacteria (Herchline, 2004). B. Diagnosis 1. Localized tender swelling "with a pointing eruption either on the internal or on the
external side of eyelid" (Bessette, 2004). 2. Conjunctiva may be infected. 3. Fever or swollen distant preauricular nodes indicates systemic disease (Bessette, 2004). II. Treatment and Medication A. Treatment is
topical unless infection is systemic. B. Antibiotics (Bessette, 2004).s 1. Bacitracin ophthalmic ointment (AK-Tracin). 2. Tobramycin ophthalmic solution or ointment (Tobrex, AKTob). 3. Erythromycin (EES, E-Mycin, Ery-Tab). 4. Dicloxacillin (Dycill,
Dynapen). 5. Tetracycline (Sumycin). 6. Cloxacillin (Cloxapen, Tegopen). III. Pharmackinetic Processes A. Bacitracin and Tobramycin: interfere with cell wall function in the gram-positive bacteria. B. Erythromycin: interferes with cell wall
function. C. Dicloxacillin: "For treatment of infections caused by penicillinase-producing staphylococci" (Bessette, 2004). D. Tetracycline: broad action against "both gram-positive and gram-negative organisms as well as infections caused by mycoplasmal,
chlamydial, and rickettsial organisms" (Bessette, 2004). Inhibits bacterial protein synthesis (Bessette, 2004). E. Cloxacillin: "For treatment of infections caused by penicillinase-producing staphylococci" (Bessette, 2004). IV. Common Drug Interactions A.
Bacitracin: none reported. B. Tobramycin: "Effects decrease when used concurrently with gentamicin" (Bessette, 2004). C. Erythromycin: "Coadministration may increase toxicity of theophylline, digoxin, carbamazepine, and cyclosporine; may potentiate anticoagulant effects
of warfarin; coadministration with lovastatin and simvastatin increases risk of rhabdomyolysis" (Bessette, 2004). D. Dicloxacillin: "Decreases efficacy of oral contraceptives; increases effects of anticoagulants; probenecid and disulfiram may increase penicillin
...